We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Rheumatology

Journal Scan / Research · June 29, 2021

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis

JAMA: The Journal of the American Medical Association

 

Additional Info

JAMA: The Journal of the American Medical Association
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial
JAMA 2021 Jun 01;325(21)2178-2187, S Furuta, D Nakagomi, Y Kobayashi, M Hiraguri, T Sugiyama, K Amano, T Umibe, H Kono, K Kurasawa, Y Kita, R Matsumura, Y Kaneko, K Ninagawa, K Hiromura, SI Kagami, Y Inaba, H Hanaoka, K Ikeda, H Nakajima

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading